Pliant Therapeutics
PLRX
PLRX
160 hedge funds and large institutions have $853M invested in Pliant Therapeutics in 2024 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 55 increasing their positions, 43 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 151 → 160 (+9)
1.99% more ownership
Funds ownership: 104.43% → 106.42% (+2%)
88% less call options, than puts
Call options by funds: $1.26M | Put options by funds: $10.7M
Holders
160
Holding in Top 10
6
Calls
$1.26M
Puts
$10.7M
Top Buyers
| 1 | +$17.3M | |
| 2 | +$14.8M | |
| 3 | +$13.4M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$9.88M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$8.56M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$11.3M | |
| 3 | -$6.67M | |
| 4 |
Barclays
London,
United Kingdom
|
-$4.21M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$3.98M |